Home > Boards > US Listed > Medical - Drugs > Matinas Biopharma Hldgs, Inc. (MTNB)

News: $MTNB Top Penny Stocks to Buy Or

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
whytestocks Member Profile
Member Level 
Followed By 55
Posts 6,981
Boards Moderated 1
Alias Born 06/04/18
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/26/2019 10:00:55 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/19/2019 10:01:01 AM
Matinas BioPharma to Present at the 31st Annual Piper Jaffray Healthcare Conference GlobeNewswire Inc. - 11/18/2019 7:30:00 AM
Matinas BioPharma Reports Third Quarter 2019 Financial Results and Provides Corporate Update GlobeNewswire Inc. - 11/13/2019 6:30:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/13/2019 6:17:32 AM
Matinas BioPharma to Webcast Conference Call Discussing Third Quarter 2019 Operational and Financial Results on November 13, ... GlobeNewswire Inc. - 11/6/2019 7:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/5/2019 4:06:57 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/5/2019 4:06:52 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/5/2019 4:06:39 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/5/2019 4:06:22 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/5/2019 4:06:11 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/5/2019 4:05:58 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/1/2019 5:01:17 PM
Matinas BioPharma Initiates EnACT Study of MAT2203 (Oral Amphotericin B) for the Treatment of Fungal Cryptococcal Meningitis GlobeNewswire Inc. - 10/14/2019 7:00:00 AM
Matinas BioPharma Receives Orphan Drug Designation From U.S. FDA for MAT2203 for the Treatment of Cryptococcosis GlobeNewswire Inc. - 10/7/2019 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/2/2019 6:15:18 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/2/2019 6:14:49 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/2/2019 6:09:11 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/2/2019 6:07:43 PM
Matinas BioPharma to Present at the 2019 Cantor Global Healthcare Conference GlobeNewswire Inc. - 9/27/2019 8:00:00 AM
Matinas BioPharma Announces Pre-Screening of Patients to Determine Eligibility for Phase 2 ENHANCE-IT Study Against Vascepa®... GlobeNewswire Inc. - 9/25/2019 7:00:00 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 9/24/2019 5:20:53 PM
Proxy Soliciting Materials (revised) (prer14a) Edgar (US Regulatory) - 9/23/2019 4:32:49 PM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 9/13/2019 4:31:01 PM
Matinas BioPharma to Present at the H.C. Wainwright 21st Annual Global Investment Conference GlobeNewswire Inc. - 8/28/2019 7:30:00 AM
whytestocks Member Level  Monday, 11/18/19 03:00:26 PM
Re: None
Post # of 550 
News: $MTNB Top Penny Stocks to Buy Or Avoid Amid Growing Optimism

Are These Penny Stocks Set To Head Higher This Week? One of the most important things to keep in mind with regards to penny stocks is that it’s possible to generate substantial returns within a short timespan. While that may be true, an investor still needs to conduct thorough researc...

Find out more MTNB - Top Penny Stocks to Buy Or Avoid Amid Growing Optimism

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist